Earp C M, Barriere S L
Drug Intell Clin Pharm. 1985 Sep;19(9):677-9. doi: 10.1177/106002808501900913.
We examined the effects of mixing tobramycin with three cephalosporins, cefazolin, cefamandole, and moxalactam. Each cephalosporin was prepared from standard powder and diluted with human serum to concentrations of 50, 250, and 500 micrograms/ml and added to 10 micrograms/ml of tobramycin in human serum. Temperature environments of 4 degrees C (refrigeration), 24 degrees C (room temperature), and 37 degrees C (body temperature) were used and sampled at 0 hours (control), and at 8, 24, and 48 hours. The results indicated no inactivation of tobramycin by any of the cephalosporins, regardless of temperature, concentration, or contact time. These results indicate that significant inactivation of tobramycin does not occur when it is combined in vitro with moxalactam, cefamandole, or cefazolin.
我们研究了将妥布霉素与三种头孢菌素(头孢唑林、头孢孟多和拉氧头孢)混合的效果。每种头孢菌素均由标准粉剂制备,并用人血清稀释至50、250和500微克/毫升的浓度,然后添加到人血清中10微克/毫升的妥布霉素中。使用了4℃(冷藏)、24℃(室温)和37℃(体温)的温度环境,并在0小时(对照)以及8、24和48小时进行取样。结果表明,无论温度、浓度或接触时间如何,任何一种头孢菌素均未使妥布霉素失活。这些结果表明,妥布霉素在体外与拉氧头孢、头孢孟多或头孢唑林联合使用时不会发生显著失活。